Original Research
Trends of Adverse Drug Reaction Reports in a Hospitalized Psychiatric Population: Exploring Prescriber Discontinuations as Potential Unreported Adverse Drug Events
by Tammie Lee Demler, BS, PharmD, MBA, BCGP, BCPP, and Charisse Chehovich, PharmD Drs. Demler and Chehovich are with the Buffalo Psychiatric Center, New York State Office of Mental Health, and the University at Buffalo School of Pharmacy and Pharmaceutical Sciences. Dr. Demler is also with the University at Buffalo School of Medicine, Department of […]
Energy Drink Use in Adolescents With and Without ADHD: Trends and Influences
by Chiranjir Narine, MD; Jennifer Weller, PhD; and Kathleen Mathieson, PhD, CIP Dr. Narine is the Medical Director of Valleywise Behavioral Health/District Medical Group in Phoenix, Arizona. Dr. Weller is the Research Director in the Child Psychiatry Department at Valleywise Behavioral Health/District Medical Group. Dr. Mathieson is an Associate Professor with the Doctor of Health Sciences […]
Capturing Clinical Symptoms with Ecological Momentary Assessment: Convergence of Momentary Reports of Psychotic and Mood Symptoms with Diagnoses and Standard Clinical Assessments
by Philip D. Harvey, PhD; Michelle L. Miller, MS; Raeanne C. Moore, PhD; Colin A. Depp, PhD; Emma M. Parrish, BS; and Amy E. Pinkham, PhD Dr. Harvey is with the University of Miami Miller School of Medicine in Miami, Florida, and Research Service at Bruce W. Carter VA Medical Center in Miami, Florida. Ms. […]
Intellectual Disability in Morocco: A Pilot Study
by Yousra BENMAKHLOUF, PhD; Zeineb ZIAN, PhD; Kaoutar BEN MAKHLOUF; Naima GHAILANI NOUROUTI, PR; Amina BARAKAT, PR; and Mohcine BENNANI MECHITA PR Drs. Benmakhlouf, Zian, Ghailani Nourouti, Barakat, and Bennani Mechita are with Biomedical Genomics and Oncogenetics Research Laboratory, Faculty of Sciences and Techniques of Tangier, at Abdelmalek Essaadi University, Morocco, in Tétouan, Morocco. Dr. […]
Pilot Mental Health Survey, Nepal: Lessons Learned for Survey Design and Instrumentation
by Sushma Dahal, MPH; Meghnath Dhimal, PhD; Sagun Ballav Pant, MD; Pawan Sharma, MD; Kedar Marahatta, MD; Nagendra Luitel, MA; Suraj Shakya, PhD; Sweta Labh, BSc Nursing; Saroj Prasad Ojha, MD; Anjani Kumar Jha, MD; and David V Sheehan, MD, MBA, DLFAPA Drs. Dhimal and Jha and Ms. Dahal and Ms. Labh are with […]
Ethical Challenges Posed by Big Data
by Edmund G. Howe, III, MD, JD, and Falicia Elenberg, BS Dr. Howe is a Professor of Psychiatry and Medicine, Director of Medical School Programs in Ethics, and Senior Scientist at Uniformed Services University of the Health Sciences in Bethesda, Maryland. FUNDING: No funding was provided for this study. DISCLOSURES: The opinions or assertions contained […]
The Depression Inventory Development Scale: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND Trial
by Anthony L. Vaccarino, PhD; Amir H. Kalali, MD; Pierre Blier, MD, PhD; Susan Gilbert Evans, MSc; Nina Engelhardt, PhD; Jane A. Foster, PhD; Benicio N. Frey, MD, PhD; John H. Greist, MD; Kenneth A. Kobak, PhD; Raymond W. Lam, MD, FRCPC; Glenda MacQueen, MD, PhD, FRCPC; Roumen Milev, MD, PhD, FRCPsych, FRCPC; Daniel J. […]
Layperson/Plain Language Summaries: Can Sponsors, CROs, and Sites Deliver in 2020?
by Charles S. Wilcox, PhD, MPA, MBA; Leslie Franceschi, BA; and ADAM SIMMONS, MPH Dr. Wilcox is Chief Executive Officer at Praxis Research Consulting in Newport Beach, California. Ms. Franceschi is Senior Project Director at Syneos Health in Morrisville, North Carolina. Mr. Simmons is Director of Clinical Program Management at Alkermes Inc. in Boston, Massachusetts. […]
The Role of Serum Lithium Concentration on Pill Burden in Psychiatric Populations
by Charisse Chehovich, PharmD; Tammie Lee Demler, BS, PharmD, MBA, BCGP, BCPP; Emily Leppien, PharmD, BCPS; and Eileen Trigoboff, RN, PMHCNS-BC, DNS, DABFN Drs. Chehovich, Demler, and Trigoboff are affiliated with the Buffalo Psychiatric Center, New York State Office of Mental Health in Buffalo, New York and with the University at Buffalo School of Pharmacy […]
Do Patterns of Instability or Severity of Psychopathology During Screening Predict Relapse in Schizophrenic Outpatient Subjects with Moderate to Severe Negative Symptoms Assigned to Placebo?
by David G. Daniel, MD; Alan Kott, MD; Jay Saoud, Phd; Remy Luthringer, PhD; Vadym Rud, MD, PhD; Andrii Skyrpnikov, MD, PhD; Rodica Stan, MD, PhD; Veselin Palazov, MD; Xingmei Wang, MS; and Michael Davidson, MD Dr. Daniel is with Signant Health in Mclean, Virginia. Dr. Kott is with Signant Health in Prague, the Czech […]
